2017-07-01
Could albumin be a biomarker to monitor the effect of intravenous immunoglobulin on Guillain-Barré syndrome?: In reply
Publication
Publication
JAMA Neurology , Volume 74 - Issue 7 p. 872
Additional Metadata | |
---|---|
doi.org/10.1001/jamaneurol.2017.0566, hdl.handle.net/1765/101168 | |
JAMA Neurology | |
Organisation | Department of Immunology |
Fokkink, W.-J., & Jacobs, B. C. (2017). Could albumin be a biomarker to monitor the effect of intravenous immunoglobulin on Guillain-Barré syndrome?: In reply. JAMA Neurology, 74(7). doi:10.1001/jamaneurol.2017.0566 |